Skip to main content
. 2024 May 31;14(25):17612–17626. doi: 10.1039/d4ra00539b

Fig. 6. In vivo antitumor efficacy. (a) Schematic of the treatments in vivo. (b) Images of the mice harboring tumors throughout 15 days of treatments. (c) Weight change and (d) tumor growth curves of the mice in various groups after several treatments. (e) Typical images and (f) average weights of the tumors dissected from mice of various groups on the 16th day. The date are expressed as means ± SD (n = 5) (***p < 0.001, **p < 0.01, and *p < 0.05).

Fig. 6